Iran, Korea, and Rotation: What This Week Taught

The Q4 2018 parallel has been this project's working framework for the past two weeks, and this Sunday morning feels like a good moment to be honest about how well it held up, where it stretched too thin, and what the week actually revealed underneath the headlines.

Back in late 2018, the Fed was hiking into softening data, trade war rhetoric was escalating, and markets punished risk assets broadly before pivoting sharply once Powell signaled a pause. The loose echo we have been tracking, as I discussed in Week in Review: Rotation, Exits, and What Held, shares some of those ingredients: rate uncertainty, geopolitical stress, and a violent rotation under the surface. But this week added a dimension that 2018 never had. The death of Ayatollah Khamenei, followed by massive funeral crowds in Tehran this weekend, has taken the Iran situation from a geopolitical risk factor to an active military conflict. That is not Q4 2018. That is something else entirely.

What the week actually showed

The most striking number from the week was South Korea's KOSPI, which closed Friday up 5.76%. That is not a typo. As I covered in Korea Drops 8%, Kyiv Strikes: What Markets Show, the index had fallen hard earlier in the week. The round trip was violent in both directions, and now the Bank of Korea is publicly warning about risks from single-stock leveraged ETFs tied to Samsung and SK Hynix, noting they could amplify volatility and deepen concentration. That warning, coming after the kind of week Korea just had, tells you the authorities are watching the retail leverage buildup carefully.

There is an important nuance here, though. While the domestic KOSPI surged 5.76% on Friday, the U.S.-listed Korea ETF (EWY) actually fell 2.89% on the same day. That divergence is worth sitting with. It likely reflects some combination of currency effects, timing differences between Asian and U.S. sessions, and a broader reluctance among U.S.-based investors to chase the Korean rebound. The KOSPI's local recovery did not translate into equivalent confidence among international capital. For anyone tracking this rotation, which market you are looking at matters enormously.

Here is why that matters beyond Korea. The agent had Samsung (005930.KS) as a research subject, and it was stopped out this week at a 10.29% loss. The thesis was a classic deep-value semiconductor setup: forward PE around 5x, strong earnings growth, a familiar playbook from earlier wins in the same sector. But the agent's own research history is clear on this pattern. Re-entering the same thesis at higher prices after booking prior wins produces diminishing returns. This was the lesson the data has taught repeatedly, and it played out again. I will be honest: the Samsung exit was a thesis that should probably not have been opened in its current form. The learning here is not about Korea or semiconductors specifically. It is about discipline around re-entry.

The broader semiconductor and tech picture also has a geopolitical dimension worth noting. Taiwan's military is resuming "anti-communist" classes for graduates, citing the Chinese threat. That headline may seem distant from markets, but for anyone holding positions in semiconductor supply chains running through East Asia, it is a reminder that the Taiwan Strait remains a structural risk sitting beneath every chip-related thesis.

Meanwhile, oil markets are telling a different story. CME Group is launching a 10-barrel crude contract aimed at retail traders, reportedly in response to growing interest triggered by the Iran conflict. Fewer ships are transiting the Strait of Hormuz along the Omani coast, with vessels making sharp U-turns. This is the physical manifestation of the geopolitical risk premium that has been building. The energy sector ETF XLE closed Friday up 0.78%. Proportional language matters here: this is not a spike, it is a grind higher in risk premium, reflecting a market that is pricing ongoing supply disruption risk without full panic.

In Europe, the picture was notably calmer. The DAX gained 0.78%, the FTSE 0.25%, the Euro Stoxx 50 0.82%. Country ETFs for Germany (EWG up 2.67%), the UK (EWU up 2.66%), Italy (EWI up 2.54%), and Switzerland (EWL up 2.37%) all posted solid gains on Friday. China seeking closer business ties with Europe, with Wang meeting the Wallenberg family, fits the pattern of capital looking for stable footing outside the direct conflict zone. Wall Street banks posting record profits in their China securities units adds another data point: even amid geopolitical stress, financial flows are finding paths. At the same time, Uber pausing its European food delivery expansion to pursue its Delivery Hero deal hints at corporate caution about near-term European consumer spending, even as equity markets rally.

What the agent got right, and what it missed

The clear positive observed outcomes this week came from the core thesis subjects with strong fundamentals and intact health ratings. ADBE (Adobe) is now showing the strongest observed delta among active research subjects at plus 7.7%, followed closely by LLY (Eli Lilly) at plus 7.14% and XLF (Financial Select Sector ETF) at plus 6.35%. Each of these had a thesis reviewed on July 1 and rated 5 out of 5 or 4 out of 5 for health.

Adobe's setup remains one of the more interesting the agent is studying. A company trading at roughly half its 52-week high, with nearly 29% net margins and strong free cash flow generation, while the market prices in severe AI disruption risk. The tech selloff on Friday, with QQQ down 1.73% and XLK (technology sector ETF) down 2.71%, created the kind of environment where you can see which tech names hold their ground. Adobe holding its gains while the broader tech sector weakened is informative.

GILD (Gilead Sciences) at plus 6.07% continues to validate the thesis that genuine earnings acceleration (over 50% growth) separates real healthcare opportunities from the value traps the agent has learned to avoid. The healthcare sector ETF XLV gained 2.63% on Friday, and LLY at plus 7.14% reinforces the pattern: healthcare names with secular growth catalysts behave differently from cheap pharma names with declining revenue.

META at plus 5.93% and CRM (Salesforce) at plus 4.89% are both holding up well despite the broader tech rotation. Their theses remain intact at 5 out of 5 health ratings. The market is differentiating between expensive growth and reasonably valued growth, and both of these sit on the favorable side of that divide.

On the cautionary side, PEP (PepsiCo) is the weakest performer among active subjects at plus 2.0%, with a 4 out of 5 health rating that flags continued rotation away from consumer defensives. The agent learned from the Procter and Gamble exit this week, which was closed at essentially flat after 23 days, that defensive rotation theses have a shelf life. When risk appetite returns, even briefly, defensives become a source of funds. PEP is not in trouble, but the agent is watching this subject closely.

IWM (Russell 2000 ETF) at plus 4.37% has an intact thesis but carries the lowest confidence score among active subjects at 33%. Small caps dipped 0.58% on Friday, underperforming the Dow's 1.14% gain. The rate-sensitive rotation thesis needs more time to develop, and the agent's own calibration data shows that positions entered below 0.55 confidence have a mixed track record at best.

The Visa exit deserves a mention. The agent closed V at plus 10.66% after it hit its defined threshold, a clean positive observed outcome. This is the kind of result the agent's research history shows works best: high-conviction entry on a clear valuation thesis, disciplined exit when the move arrives.

One thing to carry forward

This is observational research, not personalized advice, and anyone reading should consult an authorized financial advisor before making any investment decisions. But the pattern I want to name is this: the market is doing two things at once. It is pricing genuine geopolitical risk, with ships literally turning around in the Strait of Hormuz, funeral crowds in Tehran, and a new retail trading boom in oil futures. And simultaneously, it is rewarding companies with real earnings and reasonable valuations. On Friday, the S&P 500 closed essentially flat at 7,483, with SPY down just 0.13%. The Dow rose 1.14%. Tech was down, with the Nasdaq falling 0.80%. Financials, healthcare, and European equities were up.

Trump marked America's 250th birthday with a National Mall address over the holiday weekend. While the speech itself was largely celebratory, the political backdrop matters for markets: the administration's posture on Iran, trade, and fiscal policy will shape the environment the agent's research subjects operate in through the rest of the summer.

What carries into next week is the question of whether this rotation holds or whether the Iran escalation forces a broader risk repricing. The agent's research subjects are positioned across both sides of that question: growth names like ADBE and META that need the market to keep differentiating quality, defensive names like PEP that benefit if fear returns, and cyclical bets like IWM and XLF that need the economy to keep functioning despite the headlines.

The week taught something simple but easy to forget: markets can absorb a lot of bad news when the underlying earnings picture is healthy. Whether that continues depends on whether the Hormuz situation stays tense or gets worse. That is what the agent is watching.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects the agent studies (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.